Skip to main content
[Preprint]. 2021 Aug 9:rs.3.rs-798175. [Version 1] doi: 10.21203/rs.3.rs-798175/v1

Table 1.

Pregnancy Status at 20 Weeks’ Gestation among Pregnant People Receiving mRNA COVID-19 Vaccines in the Preconception Period and through 20 Weeks’ Gestation, CDC v-safe COVID-19 Vaccine Pregnancy Registry: December 14, 2020—July 19, 2021

All Self-reported SAB* 6–19 weeks’gestation Ongoing pregnancies at 20 weeks’ gestation Participants with ongoing pregnancy at contact prior to 20 weeks’ gestation Other pregnancy loss 6–19 weeks gestation
Characteristics n % n %± N %± n %± n %±
Total 2456 165 2022 253 16
Age at 1st eligible vaccine dose (years)
20–29 432 17.6 23 13.9 343 17.0 64 25.3 2 12.5
30–34 1205 49.1 71 43.0 1020 50.4 108 42.7 6 37.5
35–39 693 28.2 54 32.7 561 27.7 72 28.5 6 37.5
40+ 126 5.1 17 10.3 98 4.8 9 3.6 2 12.5
Race and Hispanic origin
Non-Hispanic Black 35 1.4 5 3.0 23 1.1 6 2.4 1 6.3
Non-Hispanic White 1923 78.3 113 68.5 1613 79.8 185 73.1 12 75.0
Hispanic 220 9.0 21 12.7 159 7.9 39 15.4 1 6.3
Non-Hispanic American Indian/Alaskan Native 7 0.3 0 0.0 6 0.3 1 0.4 0 0.0
Non-Hispanic Native Hawaiian/Pacific Islander 8 0.3 0 0.0 6 0.3 2 0.8 0 0.0
Non-Hispanic Asian 210 8.6 17 10.3 179 8.9 13 5.1 1 6.3
Non-Hispanic multiple races 48 2.0 7 4.2 34 1.7 6 2.4 1 6.3
Missing 5 0.2 2 1.2 2 0.1 1 0.4 0 0.0
Self-reported vaccine priority group
Non-healthcare essential worker 148 6.0 6 3.6 110 5.4 30 11.9 2 12.5
Healthcare personnel 2180 88.8 149 90.3 1822 90.1 196 77.5 13 81.3
Vaccine type
Moderna 1162 47.3 85 51.5 944 46.7 126 49.8 7 43.8
Pfizer-BioNTech 1294 52.7 80 48.5 1078 53.3 127 50.2 9 56.3
Number of vaccine doses reported
1 245 10.0 39 23.6 183 9.1 18 7.1 5 31.3
2 2211 90.0 126 76.4 1839 90.9 235 92.9 11 68.8
Timing of Dose 1
Preconception** 380 15.5 56 33.9 212 10.5 106 41.9 6 37.5
First trimester (>=2 and <14 weeks) 1230 50.1 107 64.8 971 48.0 142 56.1 10 62.5
Second trimester (>=14 and <20 weeks¶¶) 846 34.4 2 1.2 839 41.5 5 2.0 0 0.0
Timing of Dose 2 (n=2211)
Preconception** 188 8.5 19 11.5 116 5.7 50 19.8 3 18.8
First trimester (>=2 and <14 weeks) 885 40.0 91 55.2 642 31.8 145 57.3 7 43.8
Second trimester (>=14 and <28 weeks) 1125 50.9 4 2.4 1081 53.5 40 15.8 0 0.0
After pregnancy outcome 13 0.6 12 7.3 0 0.0 0 0.0 1 6.3
Comorbidities and past medical history
Obesity±± 432 17.6 34 20.6 340 16.8 57 22.5 1 6.3
Pre-existing diabetes 27 1.1 2 1.2 23 1.1 2 0.8 0 0.0
Prior SAB 675 27.5 59 35.8 549 27.2 65 25.7 2 12.5
1 Prior SAB 452 67.0 33 20.0 373 18.4 44 17.4 2 12.5
2 or more Prior SABs 223 33.0 26 15.8 176 8.7 21 8.3 0 0.0
*

Spontaneous abortion

Includes 19 live births, 5 stillbirths, 2 induced abortions after 20 gestational weeks, and 1996 pregnancies ongoing as of last interview

±

Column percentages provide among each pregnancy outcome/status; these should not be interpreted as risk estimates

Any person serving in a healthcare setting who has the potential for direct or indirect exposure to patients or infectious materials

**

Preconception defined as 4 weeks before last menstrual period up to 2 weeks after

¶¶

Second trimester vaccination for dose 1 limited to receipt at less than 20 weeks’ gestation per study criteria

±

12 cases missing information to determine body mass index for obesity